PubMed Health⌕ Search

Biomedical subjects

T Feltynowski

Publications and source records attributed to T Feltynowski.

At least 37 records · Page 2Linked to original sources
PubMed1989

[Are there correlations of hormonal activity in pheochromocytoma and serum as well as erythrocyte sodium and potassium concentrations in patients with pheochromocytoma].

Interrelationship between serum Na+, K+ concentrations and the excretion of norepinephrine (NA), epinephrine (A) in the urine was studied in 69 patients aged 15-69 with pheochromocytoma (PH), and between serum Na+, K+ concentrations and serum NA, A levels in 53 patients. Furthermore, in 15 patients correlation between Na+, K+ concentrations in erytrocytes and serum NA, A levels was estimated. Na+ and K+ concentrations were determined using photometric analysis, NA and A excretion in the urine using fluorometric method and in blood by radiometry. Hypokalemia and hyponatremia were stated in 22% and 19% of patients with PH, respectively. Only in patients with electrolytic disorders correlation of serum as well as erythrocyte Na+ concentrations with serum NA level and between serum K+ and A concentrations were proved. In the part of studied patients with PH, the NA and A excess induced disorders of electrolytic homeostasis.

Adolescent↗
PubMed1987

Plasma beta-endorphins and catecholamines before and after clonidine in essential hypertension and pheochromocytoma.

To investigate the possible release of beta-endorphins (beta EN) from tumors and to investigate their possible involvement in the hypotensive mechanism of clonidine (CLO) in pheochromocytoma (PHEO), as compared with essential hypertension (EH), we studied 12 patients with PHEO, 17 patients with uncomplicated stable EH (SEH), nine patients with borderline EH (BEH), and seven healthy volunteers (N). All subjects were hospitalized and excreted normal amounts of sodium. Mean blood pressure (MAP) and plasma beta EN, norepinephrine (NE), epinephrine (E), and dopamine (DA) were measured before and 180 min after an oral dose of 0.3 mg CLO. Following CLO, a significant (p less than 0.01) decrease in MAP was present in all groups. Plasma NE and E decreased (p less than 0.02 to p less than 0.01) in N, BEH, and SEH, but not in PHEO. DA did not change in any group. Pretreatment beta EN did not differ significantly between the groups, and following CLO it did not change in N or PHEO, while it increased significantly in BEH (p less than 0.01) and in SEH (p less than 0.02). Absolute changes in MAP correlated with those of beta EN only in the SEH group. Changes in NE or E did not correlate with changes in MAP in either group. Likewise, changes in NE or E were not correlated with those of beta EN, in N or EH, but a correlation between resting plasma E and resting beta EN concentrations was demonstrated in PHEO. These results support a role of beta EN in the hypotensive action of CLO in EH, but not in N or PHEO.(ABSTRACT TRUNCATED AT 250 WORDS)

Adrenal Gland Neoplasms↗